Literature DB >> 2957951

Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy.

Z Argov, W J Bank, J Maris, J S Leigh, B Chance.   

Abstract

31P nuclear magnetic resonance studies of a patient with phosphofructokinase deficiency in muscle provided the following new findings: First, ATP metabolism is disturbed at rest and during exercise. At rest, ATP levels are lower than normal and continue to decline during exercise. Second, exercise kinetics are normal, suggesting a normal mitochondrial fuel supply although glycolysis is blocked. Third, no "phosphate trapping" is observed during prolonged low-level exercise. Fourth, postexercise recovery is abnormally prolonged by the slow dephosphorylation of sugar phosphates, which has an in vivo half-life of about nine minutes. These findings demonstrate how muscle tissue adapts to a block in a major bioenergetic pathway.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957951     DOI: 10.1002/ana.410220112

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Interrelations of ATP synthesis and proton handling in ischaemically exercising human forearm muscle studied by 31P magnetic resonance spectroscopy.

Authors:  G J Kemp; M Roussel; D Bendahan; Y Le Fur; P J Cozzone
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

2.  31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients.

Authors:  G E Moore; L A Bertocci; P L Painter
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

3.  Muscle bio-energetics in acute glycolytic block: in vivo phosphorus-nuclear magnetic resonance study of iodo-acetate injected rats.

Authors:  Z Argov; D Nagle; U Giger; J S Leigh
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

4.  Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome.

Authors:  D J Taylor; M J Brosnan; D L Arnold; P J Bore; P Styles; J Walton; G K Radda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

5.  Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats.

Authors:  Z Argov; P F Renshaw; B Boden; A Winokur; W J Bank
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Energy metabolism during exercise in patients with β-enolase deficiency (GSDXIII).

Authors:  Astrid Emilie Buch; Olimpia Musumeci; Ralph Wigley; Mads Peter Godtfeldt Stemmerik; Anne-Sofie Vibæk Eisum; Karen Lindhardt Madsen; Nicolai Preisler; David Hilton-Jones; Ros Quinlivan; Antonio Toscano; John Vissing
Journal:  JIMD Rep       Date:  2021-06-14

7.  Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.

Authors:  Miguel García; Anna Pujol; Albert Ruzo; Efrén Riu; Jesús Ruberte; Anna Arbós; Anna Serafín; Beatriz Albella; Juan Emilio Felíu; Fátima Bosch
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

8.  Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1).

Authors:  Rosie J Naylor; Leanda Livesey; John Schumacher; Nicole Henke; Claire Massey; Kenny V Brock; Marta Fernandez-Fuente; Richard J Piercy
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

9.  Muscle phosphoglycerate mutase (PGAM) deficiency in the first Caucasian patient: biochemistry, muscle culture and 31P-MR spectroscopy.

Authors:  G Vita; A Toscano; N Bresolin; G Meola; F Fortunato; A Baradello; B Barbiroli; C Frassineti; P Zaniol; C Messina
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

10.  Loss of skeletal muscle HIF-1alpha results in altered exercise endurance.

Authors:  Steven D Mason; Richard A Howlett; Matthew J Kim; I Mark Olfert; Michael C Hogan; Wayne McNulty; Reed P Hickey; Peter D Wagner; C Ronald Kahn; Frank J Giordano; Randall S Johnson
Journal:  PLoS Biol       Date:  2004-08-24       Impact factor: 8.029

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.